The number of physicians that recorded disease activity in each patient as flare (F) present, and in brackets the number that scored mild (m), moderate (M) or severe (S) flare, versus the number that recorded no flare using the three instruments (BILAG 2004 index, SELENA flare instrument and PGA) and the results of the panel assessment
| Patient | BILAG 2004 | SELENA | PGA | Panel | |||
|---|---|---|---|---|---|---|---|
| F (m, M, S) | No F | F (m, M, S) | No F | F (m, M, S) | No F | Flare (Y/N (type)) | |
| A | 4 (2, 1, 1) | 0 | 2 (0, 2, 0) | 2 | 2 (0, 2, 0) | 2 | Y (M) |
| B | 1 (1, 0, 0) | 3 | 3 (2, 1, 0) | 1 | 3 (2, 1, 0) | 1 | Y (M) |
| C | 4 (0, 1, 3) | 0 | 4 (0, 1, 3) | 0 | 4 (0, 1, 3) | 0 | Y (S) |
| D | 4 (0, 0, 4) | 0 | 4 (0, 1, 3) | 0 | 4 (0, 2, 2) | 0 | Y (M) |
| E | 2 (2, 0, 0) | 2 | 3 (2, 1, 0) | 1 | 3 (3, 0, 0) | 1 | N |
| F | 4 (0, 0, 4) | 0 | 4 (0, 1, 3) | 0 | 4 (1, 1, 2) | 0 | Y (M) |
| G | 1 (1, 0, 0) | 3 | 4 (4, 0, 0) | 0 | 4 (4, 0, 0) | 0 | Y (m) |
| H | 4 (3, 1, 0) | 1 | 4 (1, 3, 0) | 0 | 4 (3, 1, 0) | 0 | Y (m) |
| I | 4 (4, 0, 0) | 0 | 4 (0, 4, 0) | 0 | 4 (0, 4, 0) | 0 | Y (M) |
| J | 4 (0, 0, 4) | 0 | 4 (0, 0, 4) | 0 | 4 (0, 0, 4) | 0 | Y (S) |
| K | 4 (0, 0, 4) | 0 | 2 (0, 1, 2) | 2 | 3 (1, 1, 1) | 1 | Y (S) |
| L | 4 (0, 0, 4) | 0 | 4 (0, 2, 2) | 0 | 4 (0, 2, 2) | 0 | Y (S) |
| M | 4 (0, 0, 4) | 0 | 4 (0, 2, 2) | 0 | 4 (0, 2, 2) | 0 | Y (m) |
| N | 4 (0, 0, 4) | 0 | 4 (0, 0, 4) | 0 | 4 (0, 0, 4) | 0 | Y (S) |
| O | 4 (0, 3, 1) | 0 | 4 (1, 2, 1) | 0 | 4 (2, 2, 0) | 0 | Y (M) |
| P | 4 (1, 0, 3) | 0 | 4 (0, 4, 0) | 0 | 4 (1, 2, 1) | 0 | Y (m) |
BILAG, British Isles Lupus Assessment Group; PGA, physician's global assessment; SELENA, safety of oestrogens in lupus erythematosus national assessment.